Rosa Lidia Estrada is a Fremont, California based nurse practitioner. Active license number of Rosa Lidia Estrada is 611123 in California. Her current practice location is 3873 Milton Ter, Fremont. Patients can reach her at 510-898-8653 and her NPI number (Unique professional ID assigned by NPPES) is 1134792153. Rosa Lidia Estrada has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Rosa Lidia Estrada speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1134792153
NPI Enumeration Date:
19 Jul, 2021
NPI Last Update On:
04 Sep, 2021
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rosa Lidia Estrada are as mentioned below.
License Number
Specialization
State
Status
611123
California
Primary
18489
Physician Assistant
California
Secondary
16513
Nurse Practitioner
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Rosa Lidia Estrada 3873 Milton Ter, Fremont, California
Zip:
94555-2244
Patients can reach Rosa Lidia Estrada at 3873 Milton Ter, Fremont, California or can call to book an appointment on 510-898-8653.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.